Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
- 1 July 2005
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 49 (1) , 1-12
- https://doi.org/10.1016/j.lungcan.2004.12.008
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseasesInternational Journal of Cancer, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Mutant DNA in Plasma of Lung Cancer Patients: Potential for Monitoring Response to TherapyAnnals of the New York Academy of Sciences, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Detecting lung cancer in plasma with the use of multiple genetic markersInternational Journal of Cancer, 2003
- Lung Cancer Screening with CT: Mayo Clinic ExperienceRadiology, 2003
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Annual screening using chest X-ray examination for the diagnosis of lung cancerCancer, 1993
- Sputum occult blood screening for lung cancer. Stage II screening of 14,431 subjectsCancer, 1991
- Indoor Radon and Lung CancerNew England Journal of Medicine, 1989